Form4insider filings, from the source

Insider holders · CIK 0001401040

DiaMedica Therapeutics Inc. · DMAC

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Zhenyu XiaoDirector7,1001,000,0001,007,100Dec 11, 2018 · 4:48 pm ESTForm 4
Hermeda Industrial Co., Ltd10% Owner3,8501,000,0001,003,850Dec 6, 2018 · 6:31 pm ESTForm 3
Randall Michael GiuffreDirector85,80454,186139,990Dec 11, 2018 · 4:17 pm ESTForm 4
Dietrich John PaulsPresident & CEO128,791—128,791Aug 12, 2026 · 4:23 pm EDTForm 4
Richard D. PilnikDirector23,838—23,838Dec 11, 2018 · 4:37 pm ESTForm 4
James T. ParsonsDirector6,100—6,100Dec 11, 2018 · 4:27 pm ESTForm 4
Scott KellenCFO and Secretary3,290—3,290Dec 11, 2018 · 4:22 pm ESTForm 4
Todd A. VerdoornChief Scientific Officer2,000—2,000Dec 11, 2018 · 4:42 pm ESTForm 4
Harry W Alcorn Jr.Chief Medical Officer1,000—1,000Dec 11, 2018 · 4:08 pm ESTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.